Detalhe da pesquisa
1.
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application.
Ther Innov Regul Sci
; 48(2): 200-207, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30227498